Upregulation of serum expression of miR-217 in non alcoholic fatty liver disease
- 1Department of Chemistry, Biochemistry Division, Faculty of Science, Fayoum University, El- Fayoum, Egypt
- 2Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Fayoum University, El- Fayoum, Egypt
Abstract
Alongside the rise in obesity and other metabolic dysfunction components, non-alcoholic fatty liver disease (NAFLD) has grown more widespread. Obesity, T2DM and hyperlipidemia are main risk factors. This condition incorporates a wide variety of clinical manifestations, from steatosis, NASH, fibrosis and cirrhosis. MiR-217 exerts a significant influence in numerous biological processes. This study was carried out to examine miR-217 expression and its potential contribution to NAFLD pathophysiology. Thirty patients with NAFLD and thirty healthy controls participated in the current study. The chosen miR-217 expression profile and its possible correlation with clinical and laboratory indicators were assessed using RT-PCR. Our study revealed a significant increase of miR-217 expression in NAFLD patients versus control ones (with a p < 0.0001). Furthermore, according to ROC curve analysis, miR-217 showed outstanding diagnostic ability (AUC of 1, a cutoff point of 1.329, sensitivity and specificity of 100%). There was a substantial negative correlation among miR-217 and free T4 without any significantly observed correlation between miR-217 and other measured variables. In conclusion, significantly higher serum miR-217 levels in NAFLD patient compared to healthy volunteers support the notion that miR-217 is a promising biomarker for NAFLD disease and advance our knowledge of the illness.
Related
- Myeloid-Derived Growth Factor Alleviates Diabetic Non-Alcoholic Fatty Liver Disease by Up-Regulating ABCA1 and ABCG1 Expression via the AMPK/PPARγ/LXRα Pathway.
- Association between the fasting blood glucose to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in Chinese adults: a secondary analysis
- Role of the Hepatorenal Index in the Detection of HbA1c-Defined Dysglycemia in Patients With Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study
- CDKN1B undergoes liquid-liquid phase separation and attenuates lipid accumulation and inflammatory response by promoting mitophagy in non-alcoholic fatty liver disease
- Liver-spleen axis: Deciphering a crucial crosstalk in non-alcoholic fatty liver disease progression and therapeutic implications
BibTeX
@article{sayed2026upregulation,
title = {{Upregulation of serum expression of miR-217 in non alcoholic fatty liver disease}},
author = {Ola N. Sayed and Azza M. Elamir and Esraa A.G. Hamad and Mervat M. El-Sayed},
journal = {Molecular Biology Research Communications},
year = {2026},
month = nov,
doi = {10.22099/mbrc.2026.56532.2319},
url = {https://doi.org/10.22099/mbrc.2026.56532.2319},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Upregulation of serum expression of miR-217 in non alcoholic fatty liver disease
AU - Ola N. Sayed
AU - Azza M. Elamir
AU - Esraa A.G. Hamad
AU - Mervat M. El-Sayed
PY - 2026
DA - 2026/11/04
JO - Molecular Biology Research Communications
DO - 10.22099/mbrc.2026.56532.2319
UR - https://doi.org/10.22099/mbrc.2026.56532.2319
AB - Alongside the rise in obesity and other metabolic dysfunction components, non-alcoholic fatty liver disease (NAFLD) has grown more widespread. Obesity, T2DM and hyperlipidemia are main risk factors. This condition incorporates a wide variety of clinical manifestations, from steatosis, NASH, fibrosis and cirrhosis. MiR-217 exerts a significant influence in numerous biological processes. This study was carried out to examine miR-217 expression and its potential contribution to NAFLD pathophysiology. Thirty patients with NAFLD and thirty healthy controls participated in the current study. The chosen miR-217 expression profile and its possible correlation with clinical and laboratory indicators were assessed using RT-PCR. Our study revealed a significant increase of miR-217 expression in NAFLD patients versus control ones (with a p < 0.0001). Furthermore, according to ROC curve analysis, miR-217 showed outstanding diagnostic ability (AUC of 1, a cutoff point of 1.329, sensitivity and specificity of 100%). There was a substantial negative correlation among miR-217 and free T4 without any significantly observed correlation between miR-217 and other measured variables. In conclusion, significantly higher serum miR-217 levels in NAFLD patient compared to healthy volunteers support the notion that miR-217 is a promising biomarker for NAFLD disease and advance our knowledge of the illness.
SN - 2322-181X
SN - 2345-2005
ER -